Journal for ImmunoTherapy of Cancer (Nov 2023)
133 The 31-gene expression profile test stratifies recurrence-free and melanoma-specific survival in patients with stage IB-IIA and stage IIB cutaneous melanoma
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)